BLCO
USDBausch + Lomb Corporation Common Shares
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$15.470
Kõrge
$15.554
Madal
$15.300
Maht
0.81M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
5.5B
Tööstusharu
Medical Instruments & Supplies
Riik
Canada
Kauplemisstatistika
Keskmine maht
0.52M
Börs
NYQ
Valuuta
USD
52 nädala vahemik
Seotud uudised
Bausch + Lomb to Hold Investor Day on Nov. 13
Bausch + Lomb Corporation (NYSE/TSX:BLCO), a leading global eye health company dedicated to helping people see better to live better, will hold an investor day on Thursday, Nov. 13, 2025, at the New York Stock
Barclays Maintains Equal-Weight on Bausch & Lomb, Raises Price Target to $17
Barclays analyst Matt Miksic maintains Bausch & Lomb with a Equal-Weight and raises the price target from $16 to $17.
HC Wainwright & Co. Maintains Buy on Bausch & Lomb, Raises Price Target to $17
HC Wainwright & Co. analyst Yi Chen maintains Bausch & Lomb with a Buy and raises the price target from $16 to $17.
JP Morgan Maintains Neutral on Bausch & Lomb, Raises Price Target to $16
JP Morgan analyst Robbie Marcus maintains Bausch & Lomb with a Neutral and raises the price target from $13 to $16.
Evercore ISI Group Maintains Outperform on Bausch & Lomb, Raises Price Target to $18
Evercore ISI Group analyst Vijay Kumar maintains Bausch & Lomb with a Outperform and raises the price target from $17 to $18.
Wells Fargo Maintains Equal-Weight on Bausch & Lomb, Raises Price Target to $16
Wells Fargo analyst Larry Biegelsen maintains Bausch & Lomb with a Equal-Weight and raises the price target from $15 to $16.
Raymond James Reiterates Outperform on Bausch & Lomb, Raises Price Target to $19
Raymond James analyst Gary Nachman reiterates Bausch & Lomb with a Outperform and raises the price target from $18 to $19.
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.